Structured Product Labeling (SPL) HT9426-26-Q-E022

Notice ID:PANDHA-26-P-0000035401

The Office of Regulated Activities of the DHA R&D – MRDC requires services to manage, process, and complete initial labeling and labeling changes for electronic Structured Product Labeling (SPL) submissions to the FDA. The contractor will handle SPL submissions for up to 5 levels of primary and secondary labeling for the agency's 2 licensed New Drug Application products. No specific timelines, budget amounts, or location for performance of services are mentioned in the description.

Structured Product Labeling (SPL) HT9426-26-Q-E022

Notice ID:PANDHA-26-P-0000035401

The Office of Regulated Activities of the DHA R&D – MRDC requires services to manage, process, and complete initial labeling and labeling changes for electronic Structured Product Labeling (SPL) submissions to the FDA. The contractor will support SPL submissions for up to 5 levels of primary and secondary labeling for the organization's 2 licensed New Drug Application products. No specific timelines, budget amounts, or location for performance of services are mentioned in the description. This opportunity involves specialized regulatory and technical expertise in HL7 standards and FDA submission processes. Prospective bidders should assess their capability to handle complex electronic labeling documentation for government medical research entities.

Structured Product Labeling (SPL) HT9426-26-Q-E022

Notice ID:PANDHA-26-P-0000035401

The Office of Regulated Activities of the DHA R&D – MRDC requires services to manage, process, and complete initial labeling and labeling changes for electronic Structured Product Labeling (SPL) submissions to the FDA. The contractor will handle SPL submissions for up to 5 levels of primary and secondary labeling for the agency's 2 licensed New Drug Application products. No specific timelines, budget amounts, or location for performance of services are mentioned in the description.

Structured Product Labeling (SPL) HT9426-26-Q-E022

Notice ID:PANDHA-26-P-0000035401

The Office of Regulated Activities of the DHA R&D – MRDC requires services to manage, process, and complete initial labeling and labeling changes for electronic Structured Product Labeling (SPL) submissions to the FDA. This involves supporting up to 5 levels of primary and secondary labeling for 2 currently licensed New Drug Application (NDA) products. The work is based on the HL7 standard for exchanging product information. No specific budget amounts, performance location, or non-bid timelines are mentioned in the description.

Structured Product Labeling (SPL) HT9426-26-Q-E022

Notice ID:PANDHA-26-P-0000035401

The Office of Regulated Activities of the DHA R&D – MRDC requires services to manage, process, and complete initial labeling and labeling changes for electronic Structured Product Labeling (SPL) submissions to the FDA. The contractor will handle SPL submissions for up to 5 levels of primary and secondary labeling for the agency’s 2 licensed New Drug Application products. No specific timelines, budget amounts, or location for performance of services are mentioned in the description. This opportunity focuses on regulatory compliance and document submission expertise. Prospective bidders should assess their capability in FDA SPL standards and pharmaceutical labeling processes.

Structured Product Labeling (SPL)

Notice ID:PANDHA-26-P-0000035401

The Office of Regulated Activities of the DHA R&D – MRDC requires services to manage, process, and complete initial labeling and labeling changes for electronic Structured Product Labeling (SPL) submissions to the FDA. The contractor will handle SPL submissions for up to 5 levels of primary and secondary labeling for the agency’s 2 licensed New Drug Application products. No specific budget amounts, submission timelines, or performance location are mentioned in the description. This opportunity involves specialized regulatory work with FDA standards, including HL7 and ANSI-accredited formats. The prospective bidder should assess their expertise in pharmaceutical labeling and FDA submission processes to determine interest.